Introduction
Apoptosis, or programmed cell death, is a physiological process essential to the normal development and homeostasis of multicellular organisms (Ellis et al., 1991; Jacobson et al., 1997) . Cells undergoing apoptosis display a pattern of morphological changes, including cytoplasmic shrinkage, chromatin condensation, membrane blebbing, DNA fragmentation and generation of apoptotic bodies that are rapidly phagocytosed by neighboring cells (Kerr et al., 1972) . Derangement of apoptosis contributes to the pathogenesis of several human diseases including neurodegenerative disorders, autoimmune disease, and cancer (Ellis et al., 1991; Cohen et al., 1992; Ra, 1992; Hunter, 1997) .
The c-Myc proto-oncogene is a transcriptional factor implicated in the control of cell cycle progression and the induction of neoplasia. The biological functions of c-Myc in normal and transformed cells are considered to be similar if not identical, and numerous observations indicate that c-Myc is a central regulator of cellular proliferation in response to extracellular stimuli. c-Myc expression can be induced by a wide spectrum of mitogenic stimuli, including platelet-derived growth factor (PDGF) (Sachinidis et al., 1993) and colony stimulating factor 1 (CSF 1) (Roussel et al., 1991) . c-Myc is also a target for transforming growth factor beta (TGF-b), being downregulated at the RNA and protein levels in cells that undergo growth arrest following TGF-b treatment . Furthermore, antisense myc oligonucleotides that inhibit synthesis of c-Myc protein inhibit proliferation of skin keratinocytes ) and hematopoietic cells (Loke et al., 1988) , and prevent entry into S phase of activated lymphocytes (Heikkila et al., 1987) , providing compelling evidence that c-Myc expression is necessary for cell proliferation. However, overexpression of c-Myc does not only stimulate cell proliferation but also inhibits dierentiation (LuÈ scher and Eisenman, 1990) and can predispose cells to apoptosis when survival factors are limiting (Evan et al., 1992; Amati et al., 1993) . c-Myc-dependent apoptosis has been demonstrated in a variety of cell types including ®broblasts (Evan et al., 1992; Amati et al., 1993) , vascular smooth muscle cells (Bennett et al., 1995) , and hematopoietic cells (Askew et al., 1991) , suggesting that it may be a general phenomenon. In some cases, physiological signals or activation of a speci®c signal transduction pathway can block c-Mycmediated apoptosis. For example, signals from the insulin growth factor 1 (IGF1) and PDGF receptors counteract the c-Myc-induced apoptotic pathway at many levels in Rat-1 ®broblasts (Harrington et al., 1994) .
TGF-b is a multifunctional protein that plays a pivotal role in the control of cellular growth, dierentiation, and cell death. Originally identi®ed by its ability to stimulate the soft-agar growth of normal rat kidney ®broblasts (Roberts et al., 1981) , TGF-b has been subsequently shown to inhibit the proliferation of a wide variety of cell types including most normal and transformed cells (Roberts et al., 1985; Moses et al., 1990) . TGF-b also aects many other biological functions, including dierentiation, motility, extracellular matrix formation, and modulation of important immune and in¯ammatory cell responses Kingsley, 1994; Derynck and Feng, 1997) . TGFb signaling is initiated when ligand induces formation of a heteromeric complex between the type I (TbRI) and type II (TbRII) serine/threonine kinase receptors (Wrana et al., 1992 (Wrana et al., , 1994 . The type II receptor is a constitutively active serine/threonine kinase that can bind TGF-b independently, but cannot signal without the type I receptor (Wrana et al., 1994) . Bound TGF-b is then recognized by type I receptor, which is recruited into the complex and becomes phosphorylated by the receptor II kinase, thereby allowing propagation of the signals to downstream components (Wrana et al., 1994) .
Recently, Smad (mothers against Dpp) proteins and c-Jun N-terminal Kinase (JNK) have been identi®ed in a variety of cell types as essential downstream components of the signal transduction pathways that are required for serine/threonine kinase receptor signaling (Heldin et al., 1997) . Smad2 and Smad3 are directly phosphorylated by ligand-activated TGF-b receptors, oligomerize with Smad4, and are translocated into the nucleus (MassagueÂ , 1996; Derynck and Feng, 1997; Heldin et al., 1997) . In the nucleus, Smad2 and Smad3 associate with DNA and other DNA-binding proteins such as FAST1, FAST2 and c-Fos/c-Jun and act as transcriptional activators for TGF-b-responsive genes (reviewed in Derynck et al., 1998) . The upstream signaling events initiated by TGF-b receptors to activate JNK are rather complex. They seem to be largely mediated through the Mitogen-activated protein Kinase Kinase (MEK or MKK) kinases MEKK1 to MKK4, the direct upstream activator of JNK (At® et al., 1997a; Frey and Mulder, 1997; Wang et al., 1997; Hocevar et al., 1999) . JNK is thought to be responsible for phosphorylating the transactivation domain of c-Jun protein in vivo, and, in turn, phosphorylated c-Jun homodimers have potent AP-1 activity and can control the expression of a number of genes, including c-jun itself (Angel et al., 1988; DeÂ rijard et al., 1994) .
Whereas the loss of growth inhibition by TGF-b frequently accompanies the progression of malignancy and may contribute to the development of many types of human cancers, expression of TGF-b is actually increased in many advanced human cancers. The elevated level of TGF-b is proposed to promote tumor progression and invasiveness, primarily through paracrine eects on stromal elements such as increased proliferation, angiogenesis, ®brosis, and immunosuppression (reviewed in Derynck and Feng, 1997) . These observations are consistent with the hypothesis that the TGF-b system has tumor suppressor activity early in tumorigenesis, but has oncogenic eect later as tumor aggressiveness increases. Although the ability of TGF-b to promote growth arrest through Smad signaling pathways is reasonably well understood, the mechanism underlying acquisition of the oncogenic eect of TGF-b has not yet been explained. In the present study, we demonstrate that TGF-b can function to inhibit cMyc-induced cell death, and this may allow c-Myc to express its proliferative potential. Our ®ndings also describe a mechanism whereby JNK cascade and Smad2 protein positively and negatively mediate TGF-b-dependent cell survival.
Results

TGF-b suppresses c-Myc-induced cell death
We ®rst investigated the ability of TGF-b to in¯uence cell survival of Rat-1 ®broblasts containing a normal cmyc gene driven by a constitutive promoter (human cytomegalovirus, CMV). In agreement with previous studies, withdrawal of survival factors led to the rapid and synchronous apoptosis of Rat-1/c-Myc cells (Evan et al., 1992) . The c-Myc-expressing cells displayed the typical characteristics of adherent cells undergoing apoptosis, becoming rounded, condensed, and detaching from the dish (Figure 1a) . In contrast, Rat-1 cells transfected with a control vector were signi®cantly protected from cell death and the accompanying morphological alterations of apoptosis ( Figure 1a) . Interestingly, microscopic examination revealed that TGF-b provided protective eect against c-Mycinduced cell death in the absence of any other exogenous growth factors or nutrients ( Figure 1a ). The appearance of Rat-1/c-Myc treated with TGF-b was indistinguishable from cells maintained in 10% fetal calf serum (FCS). Control Rat-1 ®broblasts grew as¯at and displayed a normal morphology, irrespective of whether they were cultured in the absence or presence of FCS ( Figure 1a ). Hoechst staining of Rat-1/c-Myc nuclei indicated that 24 h after serum withdrawal, approximately a third of the cell population already displayed a small, brightly stained and highly condensed nucleus, a feature not seen when the vector control line was used (Figure 1b) . Signi®cantly, addition of TGF-b to the culture suppressed the c-Myc-induced cell death (Figure 1b) . Similar results were obtained when the extent of apoptosis was determined by measuring DNA laddering, characteristic of apoptotic cell death (data not shown).
In order to quantitate these results, the viability of oating and adherent Rat-1/c-Myc and Rat-1 cells was examined by¯ow cytometric DNA analysis, where the proportion of cells with subdiploid amounts of DNA, indicative of apoptosis, was determined. The results of this analysis indicated that over 40% Rat-1/c-Myc cells showed morphological changes consistent with apoptosis, while less than 15% exhibited similar morphology in the corresponding cells that have been treated with TGF-b (see Figures 2d and 5d ). Taken together, these ®ndings demonstrate that TGF-b can speci®cally enhance cellular resistance to apoptosis induced by deregulated c-Myc expression in Rat-1 ®broblasts.
Expression of Smad2 dramatically increased c-Myc-induced cell death
Activation of TGF-b signaling results in phosphorylation of Smad2 by the activated type I receptor on Cterminal residues. Once phosphorylated, Smad2 forms a stable complex with Smad4, and this complex translocates into the nucleus where it aects transcription of target genes (reviewed in Derynck et al., 1998) . To investigate the functional importance of Smad2 in TGF-b-mediated cell survival, we examined if TGF-b could promote Smad2 phosphorylation and its transcriptional activity in both Rat-1 and Rat-1/c-Myc cells. To test Smad2 phosphorylation, Rat-1 or Rat-1/ c-Myc cells were treated with TGF-b and relative phosphorylation levels were assessed by immunoblotting with an antiphospho-Smad2 antibody that speci®cally recognizes TGF-b receptor-phosphorylated Smad2. As described previously for several cell lines, TGF-b addition to either Rat-1 or Rat-1/c-Myc cells induced strong increase in the phosphorylation of the protein. This increase was rapid and transient, being maximal 15 min after TGF-b addition (Figure 2a ). Anti-Smad2 immunoblotting of cell lysates showed that similar amounts of Smad2 were examined (Figure 2a ). To determine whether the increase in Smad2 phosphorylation correlated with the increase in its transcriptional activity, we used a Gal4-based system to examine the ability of TGF-b to enhance transcription in these cells. Fusion of Smad2 with the Gal4-DNA binding domain was constructed and cotransfected with a luciferase reporter construct containing a minimal promoter coupled to ®ve tandem Gal4 binding sites. As shown in Figure 2b To test the hypothesis that Smad2 may contribute to the inhibition of c-Myc-induced cell death by TGF-b, we generated Rat-1/c-Myc cells stably expressing high level of Smad2 protein (Figure 2c ). The availability of this cell line allowed us to demonstrate that Smad2 is defective in regulating apoptosis when the cells were incubated in standard growth medium containing 10% FCS ( Figure  2d ). However, upon serum withdrawal, we have found that the expression of Smad2 resulted in a dramatic increase in c-Myc-induced apoptosis and blocked TGFb-dependent suppression of c-Myc-induced cell death (Figure 2d 
Activation of JNK by TGF-b
A number of recent reports from our and other laboratories support the existence of other eectors operating downstream of TGF-b receptors in addition to Smad proteins (Heldin et al., 1997) . The best characterized of these is the JNK family of cytoplasmic serine/threonine kinases (At® et al., 1997a; Frey and Mulder, 1997; Wang et al., 1997; Hocevar et al., 1999) . In order to determine whether JNK could be activated in response to TGF-b in Rat-1/c-Myc ®broblasts, we tested JNK activity in an immune-complex kinase assay using GST-jun (1 ± 79) as substrate. As shown in Figure 3b , increased JNK activity was evident 2 h after addition of TGF-b, peaked at 3 ± 4 h, and remained elevated for up to 8 h. Immunoblot analysis with anti-JNK antibody of total cell lysates demonstrated no eect of TGF-b on the amount of JNK1 proteins present in the cells (Figure 3 ).
TGF-b-induced cell survival through Rho-like GTPases and JNK cascade
Recently, we and others have reported that Rac1 and Cdc42 play an important role in TGF-b-mediated gene expression (Mucsi et al., 1996; At® et al., 1997b) .
Furthermore, Rac1 and Cdc42 have been shown to function in the regulation of kinase cascades leading to activation of JNK (Coso et al., 1995; Minden et al., 1995) . If Rac1 and Cdc42 mediate signaling from TGF-b receptors to JNK, then dominant negative versions of these G proteins (N17Rac1 and N17Cdc42) might be expected to abrogate TGF-b-induced JNK activation ( Figure 3a ). To test this hypothesis, Rat-1/cMyc cells were transiently cotransfected with HA-JNK1 and either N17Rac1 or N17Cdc42. Figure 4a shows that overexpression of N17Rac1 or N17Cdc42 blocked the majority of TGF-b-induced activation of JNK. Anti-HA immunoblotting of immunocomplexes con®rmed that the observed decrease in JNK1 kinase activity was not due to low levels of HA-JNK1 expression in the N17Rac1 and N17Cdc42-transfected cells ( Figure 4a ). Together, these data provide strong evidence that Rac1 and Cdc42 play an important role in TGF-b-dependent activation of JNK.
To investigate the possibility that Rho-like GTPases and JNK cascade are intermediates in TGF-b-mediated suppression of c-Myc-induced cell death, we ®rst tested the ability of constitutively-activated mutants of Rac1 and Cdc42 to signal survival responses that are typical of TGF-b. For these assays, Rat-1/c-Myc cells were transfected with an expression vector encoding bgalactosidase (pCMV5-lacZ) together with plasmids encoding the constitutively-activated small GTPases RacL61 or Cdc42L61. After 24 h, cells were transferred Figure  3a ) sucient for protection against c-Myc-induced apoptosis. Consistent with this hypothesis, expression of the constitutively-activated mutant of RhoA (RhoL61), which did not induce JNK activation (Coso et al., 1995; Minden et al., 1995;  and data not shown), failed to inhibit c-Myc induced cell death (Figure 4b ). To provide further evidence for the involvement of Rho-like GTPases and JNK cascade in TGF-bmediated cell survival, we examined the eect of dominant-negative mutants of Rac1 and Cdc42 on the induction of cell survival by TGF-b in Rat-1/c-Myc cells (Figure 3a) . A constitutively activated form of TGF-b type I receptor, which is capable of signaling biological responses in the absence of both ligand and type II receptors (Wieser et al., 1995) , was used as a control. As shown in Figure 4c , overexpression of N17Rac1 or N17Cdc42 resulted in a complete suppression of TGF-b-induced cell survival. Under these experimental conditions, cells transfected with the constitutively activated form of TGF-b type I receptor exhibited a normal, non-apoptotic morphology either in the presence or absence of TGF-b (Figure 4c) .
To obtain direct evidence that TGF-b signals through JNK cascade to prevent c-Myc induced apoptosis, we tested the ability of MKK4 (Ala) and c-Jun TAM67 to inhibit TGF-b-dependent survival of Rat1/Myc cells (Figure 3a) . MKK4 (Ala) encodes a dominant-negative mutant with respect to JNK activation by TGF-b (At® et al., 1997b; Hocevar et al., 1999) . c-Jun TAM67 acts as a dominant-interfering mutant because of a deletion in the NH2-terminal transactivation domain of c-Jun that includes the binding site for JNK1 (DeÂ rijard et al., 1994; Rapp et al., 1994) . Interestingly, overexpression of MKK4 (Ala) or TAM67 suppressed the protective eect of TGF-b against c-Myc-induced apoptosis (Figure 4d ). Collectively, these results support a model in which the JNK cascade participates in the anti-apoptotic signaling pathway activated by TGF-b receptors through the Rho-like GTPases Rac1 and Cdc42.
Activation of JNK through Rac1 and Cdc42 is sufficient to prevent c-Myc-induced cell death
Rac1 and Cdc42 control at least two signal transduction pathways, one regulating JNK pathway and the other controlling G1 cell cycle progression and actin cytoskeleton organization (Hall, 1998) . To determine the requirement for the activation of JNK in cell survival by Rac1 and Cdc42, we have used the Rac1 and Cdc42 binding loop mutants, RacL61Y40C, Cdc42L61Y40C, RacL61F37A, and Cdc42L61F37A. RacL61Y40C and Cdc42L61Y40C were shown to induce cell cycle progression and lamellopodia but had lost their ability to induce JNK activation, whereas RacL61F37A was shown to induce JNK activation, but no longer induces G1 cell cycle progression and actin cytoskeleton organization (Lamarche et al., 1996; Westwick et al., 1997) . Unlike RacL61F37A, the F37A-substituted Cdc42 mutant is still able to induce DNA synthesis, actin polymerization, and focal complex assembly (Lamarche et al., 1996) . These various mutants were each cotransfected with the bgalactosidase-producing plasmid pCMV-lacZ into Rat-1/c-Myc ®broblasts and assessed for their ability to suppress c-Myc-dependent cell death. Whereas cells cotransfected with empty expression vector, Rac-L61Y40C, or Cdc42L61Y40C had normal appearance when incubated in standard growth medium, they assumed a characteristic apoptotic appearance, being rounded and condensed, when incubated in low serum (Figure 5a ). In contrast, cells cotransfected with pCMV5-lacZ and either RacL61F37A or Cdc42L61F37A and grown in low serum did not exhibit this morphology (Figure 5a ). From these data, it is becoming evident that the JNK pathway acts downstream of Rac1 and Cdc42 to prevent c-Mycinduced cell death. Further evidence for the speci®city Rat-1/c-Myc cells were exposed to TGF-b1 (2 ng/ml) for the indicated times. Cell lysates were immunoprecipitated with anti-JNK, and immunoprecipitates were subjected to in vitro kinase assay using GST-Jun (1 ± 79) as substrate. The phosphorylated proteins were resolved by SDS ± PAGE and visualized by autoradiography (top). Anti-JNK immunoblotting of whole cell extracts showed that similar amount of JNK1 and JNK2 proteins was recovered in each sample (bottom). Results are representative of at least three independent experiments Oncogene Suppression of c-Myc-induced cell death by TGF-b A Mazars et al of JNK signaling pathways in mediating these processes is provided by the ability of the dominantinterfering mutant MKK4 (Ala) to suppress the protective eect of RacL61F37A and Cdc42L61F37A against c-Myc-induced cell death (Figure 5a) . The transient transfection assays described above suggested that the antiapoptotic function of Rac1 and Cdc42 was linked to their ability to promote JNK activation. To con®rm these results, we generated Rat-1/c-Myc cells stably expressing the various Rac1 and Cdc42 mutants described above. To select for cells expressing the introduced Rac1 and Cdc42 mutants, drug-resistant pools of transfected cells were deprived of FCS and surviving cells rescued by readdition of FCS 5 days after deprivation. Following three rounds of this selection procedure, viable and proliferating cells were obtained from the RacL61F37A and Cdc42L61F37A-transfected cultures. In contrast, attempts to drive cells in this way from Rat-1/c-Myc cells transfected with empty vector, RacL61Y40C or Cdc42L61Y40C proved unsuccessful. In order to obtain more direct evidence that increased JNK activity through Rac1 and Cdc42 pathways prevents c-Myc-induced apoptosis, we generated independent clones of RacL61F37A or Cdc42L61F37A-expressing cells. Western blot analysis of whole-cell lysates of representative clones shows that expression of Rac1 and Cdc42 mutants varied between two-and threefold excess over endogenous Rac1 and Cdc42 levels ( Figure  5b ). Furthermore, we could not detect any alteration in the expression of exogenous human c-Myc in these cells when analysed by Western blotting (dat not shown). Consistent with published results (Lamarche et al., 1996) , RacL61F37A and Cdc42L61F37A-expressing cells had constitutive activation of endogenous JNK, compared to Rat-1/c-Myc cells (Figure 5c ). A FACScan analysis indicated that expression of RacL61F37A and Cdc42L61F37A suppressed c-Myc- induced apoptosis in the factors absence of TGF-b or any other exogenous growth factors (Figure 5d ). DNA laddering analysis or Hoechst staining of the nuclei con®rmed that RacL61F37A and Cdc42L61F37A provided suppressive eect against c-Myc-mediated cell death (data not shown).
TGF-b suppressed c-Myc-induced cell death is not linked to its ability to stimulate cell cycle progression
Following interaction with its type I and type II receptor serine/threonine kinases, TGF-b has the ability to stimulate or inhibit cell proliferation. The antiproliferative activity is best documented in epithelial cells, whereas the growth stimulatory eect occurs mainly in cells of mesenchymal origin such as ®broblasts (Derynck and Feng, 1997) . Since overexpression of a constitutively activated mutant of Rac1 that selectively stimulates JNK cascade but not G1 cell cycle progression is sucient to prevent apoptosis that is induced by c-Myc, we considered the possibility that the TGF-b-mediated cell survival may not be coupled to an increase in cell growth, as has been documented for the PDGF and IGF1-mediated cell survival in Rat-1/c-Myc ®broblasts (Harrington et al., 1994) . To explore this issue, we made the use of RacL61F37A- expressing cells, which failed to undergo apoptosis following serum deprivation, irrespective of whether they were cultured in the absence or presence of TGFb (Figure 5a,d) . If the induction of cell proliferation is a prerequisite for TGF-b to prevent c-Myc-induced cell death, one would expect that blocking apoptosis by expressing RacL61F37A would result in TGF-bindependent growth stimulation. However, there was no signi®cant dierence in the ability of TGF-b to stimulate DNA synthesis in Rat-1/c-Myc cells and those expressing RacL61F37A (Figure 6 ). Therefore, these ®ndings strongly suggest that the antiapoptotic function of TGF-b is unrelated to its growthpromoting properties as has been demonstrated for Rac1, an essential component in TGF-b-mediated cell survival.
Discussion
An emerging theme in carcinogenesis is the acquired ability of tumor cells to avoid undergoing apoptosis in response to environmental conditions that would induce a normal cell to commit suicide. For example, induction of apoptosis has been shown to accompany enhanced cell proliferation resulting from many forms of perturbation of the cell cycle, including oncogene expression or inactivation of negative regulators of the cell cycle (Hunter, 1997) . Signi®cantly several of the molecular regulators of apoptosis, such as Bcl-2, p53, and Myc, are commonly mutated or expressed in a deregulated manner in many human malignancies underscoring the importance of apoptosis in the maintenance of proliferating cell populations at equilibrium.
In the present study, we demonstrate that TGF-b can function to inhibit c-Myc-induced cell death. Protection from apoptosis correlates with the ability of TGF-b to activate JNK signaling pathways and was not linked to its ability to promote cell cycle progression. Direct evidence that activation of JNK pathways is required for cell survival by TGF-b in Rat-1/c-Myc cells comes from the observation that dominant-interfering forms of various components of the JNK signaling pathways including Rac1, Cdc42, MKK4, and c-Jun (Figure 3a ) blocked cell survival induced by TGF-b. Interestingly, the constitutively activated mutant of Rac1 (RacL61F37A), which is unable to induce G1 cell cycle progression or actin polymerization but is able to activate JNK cascade (Lamarche et al., 1996; Westwick et al., 1997) , is sucient to prevent c-Myc-induced cell death. This observation supports the notion that the antiapoptotic function of Rac is unrelated to its growth-promoting activity as demonstrated with TGF-b. A very similar situation has been described for PDGF induction of cell survival in Rat-1/c-Myc cells following growth factor withdrawal, in which the induction of G1 progression and entry into S phase of the cell cycle are not required for PDGF-mediated cell survival (Harrington et al., 1994) .
The Rho family of small G proteins, which regulate actin-containing structures and plasma membrane topology, have recently assumed increasing importance in cell growth and oncogenesis (Hall, 1998) . A number of potential eector proteins have been found to associate preferentially with the GTP-bound form of Rho family proteins. Although it is not yet known precisely which targets are essential for dierent responses induced by each family member, the use of speci®c point mutations in the eector domains of these proteins has begun to allow a dissection of the dierent pathways that can be activated (Lamarche et al., 1996; Westwick et al., 1997) . The eector binding loop mutants of activated Rac1 and Cdc42, RacL61Y40C and Cdc42L61Y40C, are unable to activate the JNK cascade. In contrast, the Rac1 eector binding loop mutant, RacL61F37A, which activates JNK, was defective in the stimulation of DNA synthesis, actin polymerization and integrin complex assembly. We show here that expression of the eector binding loop mutants RacL61Y40C and Cdc42L61Y40C are defective in suppressing apoptosis by c-Myc, implying that G1 progression and actin cytoskeleton organization are not required for the inhibition of c-Myc-induced cell death. Since expression of RacL61F37A is sucient to prevent c-Myc-induced cell death in Rat-1 ®broblasts, we speculate that JNK activation may provide an essential signal required for Rac1-induced cell survival. In support of this interpretation, we showed that expression of a dominant-negative mutant of MKK4 abolished RacL61F37A-induced cell survival in Rat-1/cMyc ®broblasts.
Our data are consistent with a model in which the JNK cascade participates in the antiapoptotic pathway activated by TGF-b receptors through Rho-family GTPases. Recently, several groups have reported that activation of the JNK pathway can also induce cell death. For example, activation of JNK in the absence of extracellular signal-regulated kinase (ERK) activity induces apoptosis in neuronal cells (Xia et al., 1995) . Furthermore, expression of MEKK, which activates JNK, resulted in the apoptotic death of ®broblasts (Johnson et al., 1996) , suggesting that under some circumstances JNK signaling alone might be sucient to cause cell death. In other studies, it has been shown that ASK1, an activating kinase of the JNK pathways that functions in response to TNF-a is sucient to Figure 6 The antiapoptotic function of TGF-b is unrelated to its growth-promoting properties. Rat-1/c-Myc and Rat-1/c-Myc cells stably expressing RacL61F37A were transferred into medium containing 0.1% FCS with various concentrations of TGF-b. After 24 h, the cells were pulsed for 2 h with [ 3 H]thymidine, and the amount of incorporated radioactivity was measured by scintillation counting. Each data was assayed in triplicate, and the replicates were within 10% of each other
Suppression of c-Myc-induced cell death by TGF-b
A Mazars et al induce apoptosis and is required for TNF-a-induced cell death (Ichijo et al., 1997) . However, in certain cell lines such as hematopoietic cells, JNK activation in response to extracellular stimuli appears to play a protective role with respect to apoptosis (Sakata et al., 1995; Nishina et al., 1997) . From these molecular studies, it is becoming increasingly clear that the regulation of programmed cell death is complex and varies considerably between dierent cell types and also between dierent forms of death-inducing insults. In any event, the ®ndings outlined in the present study provide molecular evidence that induction of cell survival by TGF-b can be achieved through the Rholike GTPases, and reveal that the activation of JNK signaling pathways is required for the prevention of cMyc-induced cell death by TGF-b. How TGF-b receptor couples to the Rho-like GTPases and JNK is still unclear. Biochemical and biological studies with Ser/Thr kinase receptors of the TGF-b family have shown that receptor activation involves transphosphorylation of receptor I by receptor II, allowing propagation of the signals to downstream components (Wrana et al., 1994) . Recently, several proteins that interact directly with TGF-b receptors have been identi®ed by biochemical means and yeast two-hybrid screens, including SARA (for Smad anchor for receptor activation) and the asubunit of farnesyltransferase (Derynck and Feng, 1997; Tsukazaki et al., 1998) . It is important to note that SARA contains a FYVE domain, which is also present in unrelated signaling molecules that include FGD1, a putative guanine exchange factor for Rho/ Rac (Wiedemann and Cockcroft, 1998) . Since FGD1 plays an important role in the activation of Rac, we are currently investigating the relationships between SARA/Rac/JNK. The farnesyltransferase is known to play a critical role in the activation of Ras by attaching a farnesyl group, thereby allowing its translocation to the membrane. Furthermore, TGF-b receptor activation induces a rapid increase of GTP binding of Ras, indicating the possible involvement of Ras signaling in the TGF-b responses (Derynck and Feng, 1997; Heldin et al., 1997) . Interestingly, stimulation of Ras signaling pathway through several receptor tyrosine kinases delivers a signal that ultimately leads to inhibition of apoptosis induced by c-Myc in Rat-1 ®broblasts (Kaumann-Zeh et al., 1997) . Given the role of Ras in activation of Rho family GTPases, one attractive possibility is that TGF-b receptors could activate an eector pathway operating downstream of Ras, which might perhaps be able to in¯uence the activity of Rac1 and Cdc42 in Rat-1/c-Myc cells. Activation of Rho family members may involve coupling of Ras through an intermediate such as PI3-kinase, which has recently been shown to promote the formation of the GTP-bound form of Rac1 (Hawkins et al., 1995) as well as cell survival Kaumann-Zeh et al., 1997; Khwaja et al., 1997) . Whatever the mechanism, our studies clearly de®ne an important role for Rho-like GTPases and JNK in the regulation of apoptosis by TGF-b. The identi®cation of downstream events that connect TGF-b receptors to Rac1 and Cdc42 signaling pathway should provide insight into the mechanism by which TGF-b promotes cell survival and cellular transformation.
Since TGF-b receptors can also trigger Smad2 activation (reviewed in Derynck et al., 1998) , we investigated whether Smad2 could function to prevent c-Myc-induced cell death. Surprisingly, we showed that overexpression of Smad2 dramatically increased apoptosis and resulted in almost complete abrogation of TGF-b-dependent suppression of c-Myc-induced cell death. Interestingly, Smad3, which also functions in TGF-b signaling, is highly related to Smad2 and interacts with the TGF-b type I receptor. Furthermore, both Smad2 and Smad3 can activate promoters such as 3TP-Lux (Derynck et al., 1998) . In several attempts, we were unable to establish Rat-1/c-Myc stably expressing Smad3, suggesting that expression of Smad3 inhibits cell growth and/or induces cell death in Rat-1/c-Myc ®broblasts (data not shown). Although this has not yet been directly investigated, it is likely that Smad3 may function similarly to Smad2 to prevent the suppression of c-Myc-induced cell death by TGF-b. At present, the basis of these opposite eects of Smad2 and TGF-b on c-Myc-induced cell death is unclear. Since TGF-b can transmit survival signals through JNK cascade, it is possible that the level of JNK activation relative to Smad2 may play an important function in de®ning the positive or negative regulation of transcriptional responses by TGF-b. Consistent with this hypothesis, we have shown that overexpression of constitutivelyactivated mutants of JNK cascade resulted in almost complete abrogation of Smad2-dependent activation of transcription from several promoters, an eect that was partially reversed when higher doses of Smad2 were transfected into the cells (Prunier and At®, unpublished data) . Further analysis will be required to address this question, and an approach that we are currently undertaking is to identify mechanisms of transmodulation between Smad2 and JNK cascade in Rat-1/c-Myc cells using a heterologous transcriptional assay, in which Smad2 or Smad3 are fused to the DNA-binding domain of the yeast transcription factor Gal4. In any case, these ®ndings describe a dierential eect of two separated signaling pathways of TGF-b and reveal a novel mechanism through which Smad2 can act as antagonist to suppress TGF-b-dependent cell survival. While the preparation of this paper was in progress, Hocevar et al. (1999) reported that TGF-b induces ®bronectin synthesis through a JNK-dependent, Smad4-independent pathway. At present, it is not known whether the induction of ®bronectin synthesis by TGF-b through JNK plays a role in suppression of apoptosis via the activation of survival molecules, such as integrins. Whatever the case, these data also support the notion that Smad proteins and JNK activation would allow cells to display diverse patterns of transcriptional responses to TGF-b dependent upon the relative activation of Smad proteins versus JNK.
Materials and methods
Cell culture and transfection
The Rat-1 cells were grown in Dulbecco's modi®ed Eagle's medium (DMEM) containing 10% fetal calf serum (FCS), 200 U/ml penicillin and 200 mg/ml streptomycin. Rat-1/cMyc cells were grown in the same medium containing G418 (200 mg/ml). To generate Smad2, Cdc42L61F37A and RacL61F37A-expressing cell lines, Rat-1/c-Myc cells were transfected with 10 mg of DNA together with 1 mg of pMO5 vector encoding a hygromycin resistance gene by the lipofectAMINE method (Gibco-BRL) and subsequently selected with 300 mg/ml hygromycin. Control cells were transfected with empty vector alone or were untransfected. Cdc42L61F37A and RacL61F37A-expressing cell lines were ®nally selected by a series of serum rescue procedures in which cells were cultured in medium in the absence of serum for 3 ± 5 days and then rescued by washing into serumcontaining medium. Independent clones of Rat-1/c-Myc stably transfected with vectors encoding Cdc42L61F37A or RacL61F37A mutants were picked and assessed for expression of Cdc42L61F37A and RacL61F37A by using anti-Rac1 or anti-Cdc42 polyclonal antibodies (Santa Cruz Biotech, CA, USA).
Gene expression
Rat-1 or Rat-1/c-Myc cells were plated to semicon¯uency in high glucose DMEM containing 10% FCS and 24 h later transfected with expression vectors by the lipofectAMINE method. Cells were subsequently incubated in the presence or absence of human TGF-b1 (2 ng/ml) for 12 h. Extracts were then prepared and assayed for luciferase activity using the luciferase assay system described by the manufacturer (Promega). Light emission was measured during the initial 30 s of the reaction using a luminometer. The luciferase activities were normalized on the basis of b-galactosidase expression from pCMV5.LacZ-Control vector.
Plasmids
Mammalian expression vector for Cdc42L61Y40C, Rac-L61Y40C, Cdc42L61F37A and RacL61F37A were a gift from Dr A Hall. Expression plasmids for constitutively activated TGF-b type I receptor (pCMV5-TbRI act) and pCMV5-Flag-Smad2 were a gift from Dr J Wrana. pCEV29-N17Cdc42, pCEV29-N17Rac1, pcDNA3-RacL61, pcDNA3-Cdc42L61, pcDNA3-RhoL61, pcDNA3-HA-JNK1, pGEX-cjun (1 ± 79), pcDNA3-MKK4 (Ala), pcDNA3-MKK4, pRSVc-Jun, pCMV-TAM67, and pCMV5-lacZ have been described (At® et al., 1997a,b) . For stable transfection, expression vector for Smad2 was constructed in pcDNA-3-Hygro and using convenient sites in the vector polylinker. For transient transfections, Smad2 was subcloned into PSG24 (a gift from Dr J MassagueÂ ) in frame with an amino-terminal Gal4-tag .
Protein kinase assay and immunoblotting
JNK activity was performed as previously described (At® et al., 1997a) . Brie¯y, cells were lysed at 48C in lysis buer containing 25 mM HEPES (pH 7.5), 0.3 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM dithiothreitol, 1% Triton X-100, 0.5% sodium deoxycholate, 20 nM b-glycerophosphate, 1 mM sodium vanadate, 1 mM phenylmethylsulfonyl¯uoride, 20 mg/ml aprotinin, and 20 mg/ml leupeptin. Lysates were centrifuged at 25 000 g for 15 min, and JNK was immunoprecipitated from the supernatants at 48C for 2 h using anity puri®ed rabbit anti-JNK antibody (Santa Cruz Biotech, CA, USA). Immunocomplexes were immobilized on sepharose coupled protein G for 30 min at 48C, washed twice in lysis buer, and once in kinase buer consisting of 12.5 mM MOPS (pH 7.5), 12.5 mM b-glycerophosphate, 7.5 mM MgCl 2 , 0.5 mM EGTA, 0.5 mM sodium¯uoride, 0.5 mM sodium vanadate. After washing, the immunoprecipitates were resuspended in buer supplemented with 2 mg of GST-Jun (amino-acids 1 ± 79), 20 mM unlabeled ATP, and 5 mCi of [g-32 P]ATP. After incubation at 308C for 20 min, the reaction was stopped by addition of SDS-sample buer. Samples were analysed by SDS-polyacrylamide gel electrophoresis and autoradiography. The HA epitope-tagged JNK1 activity was also assayed by kinase assays after immunoprecipitation with the HA monoclonal antibody 12CA5.
For Western blot analysis, proteins were electrophoretically transferred to nitrocellulose membranes and probed with antibodies. The bands were visualized by an enhanced chemiluminescent detection system according to the manufacturer's instructions (ECL, Amersham).
Assays for apoptosis
To detect DNA fragmentation in situ, cells were ®xed with methanol at 7208C for 20 min, washed with PBS, and stained with Hoechst (2 mg/ml). Cells were observed under uorescent microscope. b-galactosidase activity in cells transfected with a pCMV5-lacZ reporter plasmid and dierent expression vectors was visualized by ®xing cells with 0.5% glutaraldehyde for 15 min at 48C followed by extensive washing in PBS with 5 mM MgCl 2 . Fixed cells were stained in PBS containing 1 mg/ml X-gal, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 2 mM MgCl 2 , and 0.02% NP40 until a suitable color developed, usually 6 ± 16 h. Cells were observed microscopically. The number of blue cells was determined by counting ten dierent randomly chosen ®elds. Blue cells were included for analysis only if their morphological status could be scored unambiguously.
For¯ow cytometric determination of DNA degradation, adherent and¯oating cells were combined, washed once with PBS, and ®xed in 70% ethanol. Fixed cells were washed with PBS, incubated with 1 mg of RNase A per ml for 30 min at 378C, and stained with propidium iodide. The stained cells were analysed on a FACScan¯ow cytometer for relative DNA content. ]thymidine incorporation was performed as previously described . Brie¯y, cells were seeded in 6-well plates in DMEM supplemented with 10% FCS, grown overnight, and then incubated for 24 h with various concentrations of TGF-b. During the last 4 h of incubation, the cells were labeled with 1 mCi/ml [ 3 H]thymidine. Cells were washed three times with cold PBS and ®xed with 10% trichloracetic acid for 30 min at 48C. The cells were then washed twice with 10% trichloroacetic acid and extracted with 0.5 M NaOH for 30 min. The extracts were collected and counted in a liquid scintillation spectrometer.
